Korolczuk A et al. |
The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity. |
2014 |
J. Physiol. Pharmacol. |
pmid:25554991
|
Korbecki J et al. |
Cyclooxygenase pathways. |
2014 |
Acta Biochim. Pol. |
pmid:25343148
|
Wasinger C et al. |
Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells. |
2014 |
Br. J. Pharmacol. |
pmid:25091578
|
Paakinaho V et al. |
Electrophilic lipid mediator 15-deoxy-Δ12,14-prostaglandin j2 modifies glucocorticoid signaling via receptor SUMOylation. |
2014 |
Mol. Cell. Biol. |
pmid:24980431
|
Mantel A et al. |
Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism. |
2014 |
Exp. Dermatol. |
pmid:24917395
|
Tang J et al. |
Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway. |
2014 |
Stem Cells Dev. |
pmid:24730450
|
Liu C et al. |
15d-PGJâ‚‚ decreases PGEâ‚‚ synthesis in HBx-positive liver cells by interfering EGR1 binding to mPGES-1 promoter. |
2014 |
Biochem. Pharmacol. |
pmid:25108236
|
Koyani CN et al. |
15-deoxy-Δ¹²,¹â´-PGJâ‚‚ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis. |
2014 |
Int. J. Cardiol. |
pmid:24698234
|
Yen CC et al. |
Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. |
2014 |
Oncotarget |
pmid:24566468
|
Wang C et al. |
A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. |
2014 |
Nat. Methods |
pmid:24292485
|
GarcÃa-Bueno B et al. |
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. |
2014 |
Schizophr Bull |
pmid:23486748
|
Katsumata Y et al. |
Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2. |
2014 |
Hypertension |
pmid:24101662
|
Casali CI et al. |
Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells. |
2014 |
Biochem. Pharmacol. |
pmid:24915420
|
Tachi M et al. |
Mass spectrometric determination of prostanoids in rat hypothalamic paraventricular nucleus microdialysates. |
2014 |
Auton Neurosci |
pmid:24447364
|
Kurtz M et al. |
Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats. |
2014 |
J. Endocrinol. |
pmid:24389592
|
Chen S et al. |
15-Deoxy-Δ(12,14)-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells. |
2014 |
Chem. Biol. Interact. |
pmid:24582817
|
Yin Y et al. |
PPARγ agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages. |
2014 |
Respir. Res. |
pmid:24612634
|
Liu H et al. |
Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. |
2013 |
Neurotoxicology |
pmid:23973622
|
Bogacka I et al. |
The involvement of peroxisome proliferator activated receptors (PPARs) in prostaglandin F2α production by porcine endometrium. |
2013 |
Reprod Biol |
pmid:24287039
|
Sharvit E et al. |
Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists. |
2013 |
PLoS ONE |
pmid:24098526
|